Exclusive: EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines - sources

The European Union is negotiating advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna, Sanofi and Johnson & Johnson and biotech firms BioNtech and CureVac, two EU sources told Reuters. The talks follow a deal reached in June by four EU states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations.